Astellas prioritises therapeutic areas where there is unmet medical need for medicines that improve the quality and length of patients' lives.
With our ethos of CHANGING TOMORROW, helping people with challenging medical needs is the driving force behind our company focus and R&D efforts. In 2005, Astellas undertook a strategic analysis to identify those disease areas where available treatments offered limited value and the company was best equipped to make a genuine difference.
Based on this, we have defined five therapeutic areas as our priorities for improving the future of patients in the EMEA region:
But our focus on people isn’t just in the discovery of new medicines. We produce a wide range of established products and it is essential that we provide patients with an uninterrupted supply of high-quality medicines that they can trust and rely on. As part of our drug research and development process, we investigate the best way of manufacturing our medicines to ensure that their efficacy and safety is maintained from factory to patient.
We also have our own production standards (which exceed those required by the industry) and apply rigorous quality assurance that encompasses our manufacturing facilities, equipment and processes, as well as all stages from the procurement of raw materials through to storing and distributing our products.
Learn more about our therapy areas:
Innovative therapies in preventing organ rejection after transplantation
World-leading approach in R&D to satisfy unmet patient needs in urological conditions
Our commitment is to developing first-in-class and best-in-class therapies
Addressing the complex challenges of serious fungal and bacterial infections
Pioneering treatments that effectively manage chronic pain